SEKO Logistics and Peli BioThermal are targeting a bigger share of Ireland’s growing pharmaceutical market after extending their two-year partnership, supported by SEKO’s opening of a new 30,000 sq ft facility in Dublin.
Peli BioThermal appointed SEKO Logistics as its network station and service center in Ireland in 2019.
The success of the partnership, alongside SEKO’s investment in its new Dublin hub, has enabled Peli BioThermal to now upgrade its service offering to pharma customers in Ireland and leverage SEKO’s international freight forwarding network.
Related Post
Under the newly extended partnership, SEKO now also provides international movements of Crēdo Cargo units by Air, Sea, and Road transportation, offering Import, Export, and in-house Customs Brokerage services.
SEKO has also opened a new Crēdo Cube refurbishment operation within the facility with a GDP-certified team of staff.
Adam Tetz, director of worldwide marketing at Peli BioThermal, commented: “What we are doing with SEKO Logistics in Ireland is over and above what we typically do in other service stations and we’re keen to upgrade some of our other locations to follow this model.
SEKO’s new facility has made it easier and more cost-efficient to set up these other services and sets a precedent for future network stations.
We see massive growth potential in Ireland and the availability of these additional services broadens our scope. Working with SEKO is a great experience.
They are very supportive and accommodating, and this has enabled us to move ahead with new opportunities.”
“One of our reasons for moving to a bigger facility in Dublin was to show Peli BioThermal that we are a long-term partner ready to support their growth over the next 3-5 years,” said Michael Daly, managing director of SEKO Logistics in Ireland.
“We want to help them grow more and, in doing so, show Ireland’s pharma industry the benefits we can offer by centralizing their requirements with us. “By combining Peli BioThermal with SEKO’s international freight forwarding network and customs services, we can simplify pharma supply chains and make them more efficient,”
